Navigation Links
American Pacific Reports Fiscal 2013 Second Quarter Results; Increases Full Year Guidance
Date:5/9/2013

uarter timing when compared to the prior fiscal year.The Fine Chemicals segment reported operating income of $3.8 million for the Fiscal 2013 second quarter compared to an operating loss of $1.0 million for the Fiscal 2012 second quarter.  The improvement includes a ten percentage point increase in gross margin, offset partially by increased operating expenses.  Fine Chemicals segment operating income for the Fiscal 2013 six-month period was $5.0 million compared to a loss of $2.2 million for the six-month period in the prior fiscal year.  For the Fiscal 2013 six-month period, the gross margin percentage increased twelve percentage points.  Gross margin improvements reflect significant improvements in manufacturing operations, as well as better contractual pricing on certain core products.  Our Fine Chemicals segment has dedicated significant efforts over the last two fiscal years to improving the efficiency of its manufacturing activities.  Redesigned key processes continued to yield targeted throughput ranges during the Fiscal 2013 periods.  In contrast, during the Fiscal 2012 periods, the Fine Chemicals segment had not yet achieved the benefits of these improvements.Fine Chemicals operating expenses increased in the Fiscal 2013 periods primarily due to the timing of incentive compensation accruals.  Strong operating performance in the first half of Fiscal 2013 has resulted in incentive-based compensation costs being recorded earlier in this fiscal year than in the prior fiscal year.Specialty Chemicals SegmentOur Specialty Chemicals segment revenues include the operating results from our perchlorate, sodium azide and Halotron product lines, with our perchlorate product lines comprising 83% and 87% of Specialty Chemicals segment revenues in the Fiscal 2013 and 2012 six-month periods, respectively. 

Quarter Ended March 31, 2013 Compared to Quarter Ended March 31, 2012

  • Revenues were $11.9 million co
    '/>"/>

  • SOURCE American Pacific Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

    Related medicine technology :

    1. Eisai USA Foundation to Donate $1 Million to the Conquer Cancer Foundation of the American Society of Clinical Oncology
    2. Exosome Diagnostics Presents Data Demonstrating Utility of Urine Exosome Technology to Predict Prostate Biopsy Outcome at American Urological Association Annual Meeting
    3. Harlan Laboratories Continues Global Growth with Major Expansion of North American Facilities
    4. American Pacific To Release Financial Results And Hold Fiscal 2013 Second Quarter Investor Teleconference
    5. Ferring Announces It Will Present Phase 3 Data for Cervical Ripening Agent at American College of Obstetricians and Gynecologists Annual Clinical Meeting
    6. The Importance of Emergency Preparedness: Lilly Diabetes and the American College of Endocrinology (ACE) Help Prep People with Diabetes for Emergencies - Big or Small
    7. CIOs von GlaxoSmithKline und British American Tobacco als Referenten auf führender Strategie-Veranstaltung für Unternehmensmobilität
    8. CIOs of GlaxoSmithKline and British American Tobacco to Speak at Leading Enterprise Mobility Strategy Event
    9. Neuralstem ALS Trial Data Presented At The American Association Of Neurological Surgeons Annual Meeting
    10. American Skin Association Announces New Member Of The Board J. Michael Pearson And New Education Council Member Ryan Weldon Of Valeant Pharmaceuticals International, Inc.
    11. Shalom Jacobovitz Named CEO of American College of Cardiology
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/22/2015)... , May 22, 2015  Research and Benchmarking ... sixth Medical Affairs Roundtable on Thursday, ... a virtual roundtable to discuss "Medical Affairs, Role ... Best Practices, Medical Affairs Consortium provides Medical Affairs ... the key challenges they face. The consortium has ...
    (Date:5/22/2015)... May 22 2015 /CNW/ - The Taskforce representing ... of all the hard work that the Minister and Health ... months. This program recognizes the needs of the thalidomide survivors, ... $75,000 a year, tax free, with annual adjustments for inflation. ... for annual payments of $100,000 based on the severity of ...
    (Date:5/22/2015)... , May 22, 2015  Amgen (NASDAQ: ... has commenced termination of its participation in ... AstraZeneca (LON:AZN, STO:AZN and NYSE: AZN ... in development for patients with moderate-to-severe plaque ... decision was based on events of suicidal ...
    Breaking Medicine Technology:Best Practices Sixth Medical Affairs Consortium Roundtable to Focus on Health Economics & Outcomes Research 2Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5
    ... BLUE BELL, Pa., Feb. 2, 2011 Inovio Pharmaceuticals, ... in the development of therapeutic and preventive vaccines against ... a scientific paper in the journal Human Vaccines ... of Inovio,s SynCon™ DNA vaccine for prostate cancer targeting ...
    ... LIONVILLE, Pa., Feb. 1, 2011 West Pharmaceutical Services, Inc. ... attend the UBS 21st Annual Global Healthcare Services Conference in ... business and outlook on Tuesday, February 8, 2011 at 1:00 ... Company,s presentation, as well as a copy of the presentation ...
    Cached Medicine Technology:Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 2Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 3Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 4Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 5
    (Date:5/23/2015)... 2015 Add High-Quality prismatic refractions into footage ... , It's as simple as dragging and dropping footage into ... for full effect. , Including over 80 stunning flares, ... sensors making this the ultimate bundle for adding prismatic refractions ... this package are movie files designed for Final Cut Pro ...
    (Date:5/22/2015)... Utah (PRWEB) May 22, 2015 Mountain Point ... host a ribbon cutting ceremony on Friday, May 29, 2015 ... p.m. to 6 p.m. The new medical center, set to ... North Triumph Boulevard, Lehi, UT 84043. , “The opening ... our team and the Utah County community,” said Kent Loosle, ...
    (Date:5/22/2015)... (PRWEB) May 22, 2015 Combination ... treatment option for chronic obstructive pulmonary disorder (COPD) ... plc and AstraZeneca plc as well as Germany’s ... share and position. But will market payers, clinicians ... already well-entrenched products to completely new ones? , ...
    (Date:5/22/2015)... 2015 Coordinating care for people ... Historically providers have not been reimbursed or rewarded ... 2015, Medicare has paved the way by offering ... the launch of Oculus Health , an ... using the platform will now be able to ...
    (Date:5/22/2015)... 22, 2015 ZH Healthcare ... solutions, announced today that Bill Lane, joins ZH’s ... developer of BlueEHS,a first of its kind, Freemium ... customizable Electronic Health Records (EHR) with an integrated ... telemedicine-enabled comprehensive patient portal, and more. Combined with ...
    Breaking Medicine News(10 mins):Health News:Developers at Pixel Film Studios Release ProFlare 5K Prism for Final Cut Pro X. 2Health News:Mountain Point Medical Center, a Campus of Jordan Valley Medical Center, Hosts Ribbon Cutting Ceremony and Community Celebration on Friday, May 29, 2015 2Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Oculus Health Care Coordination Platform Officially Launched 2Health News:Oculus Health Care Coordination Platform Officially Launched 3Health News:Oculus Health Care Coordination Platform Officially Launched 4Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2
    ... NRL: THE NEW STANDARDIZED SOURCE MATERIAL FOR THE PRODUCTION ... PRODUCTS USING ... Technology Limited has invited,Vystar Corporation to present its revolutionary ... Conference 2008 in Madrid in,January. "Vytex(TM) Natural Rubber ...
    ... Spain: In a surprising finding, American scientists have found ... as well as their single counterparts in certain aspects ... study, presented today (Wednesday) at the European Cancer Conference ... 489 patients with Barretts oesophagus, a non-cancerous condition linked ...
    ... that attacks cancer in an entirely new way has ... the disease and prolonging the lives of patients. , ... Conference (ECCO 14) in Barcelona found that giving the ... the amount of time patients survived without progression of ...
    ... and Vicksburg Plants Recognized as Premier,Facilities by the Association for ... ... Magazine, BATESVILLE, Ind., Sept. ... Hillenbrand Industries (HB),announced that its two metal manufacturing facilities and ...
    ... Proposals and Variations, LOS ANGELES, Sept. ... a leading e-health Wi-Fi PDA technology provider, ... and EMR applications,and the distributor of life ... products, announced today that its Board of ...
    ... newly incorporated subsidiary of Genomatix Software GmbH, has announced that ... the NCI/NIH for the fourth consecutive year. This years renewal ... was executed entirely between the US company and the NCI/NIH ... with our progress in putting the US company on its ...
    Cached Medicine News:Health News:Global Latex Conference to Showcase Vytex(TM) NRL 2Health News:Married esophageal cancer patients fare worse in some quality of life aspects than single patients 2Health News:New type of drug shows promise in attacking melanoma in an innovative way 2Health News:Three Batesville Casket Company Production Facilities Honored for Manufacturing Expertise by National Organizations 2Health News:Three Batesville Casket Company Production Facilities Honored for Manufacturing Expertise by National Organizations 3Health News:InstaCare Corp. Reviewing M&A Plans 2
    ... drainage from the ureteropelvic junction to the ... segment with no sideports prevents postoperative narrowing ... of the ureteral wall to the stent. ... one-time use. CAUTION: Periodic evaluation is advised; ...
    Used for retrograde positioning of a ureteral stent. The radiopaque band improves fluoroscopic visibility of the positioner tip. Supplied sterile in peel-open packages. Intended for one-time use....
    ... silicone or Silitek, ACMI Single J ... healing after surgery. Following cystectomy, the ... supports the ileal intestinal anastomosis, and ... leakage. Following ureteroscopy, the Single J ...
    ... The V-Max™ Roller Bar Electrode provides ... and improve visibility during TURP procedures. The ... surface with holes. The holes have circular ... tissue ablation. This patented design was developed ...
    Medicine Products: